Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Future Medicinal Chemistry|December 15, 2015
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatmentDaniel Merk
Expert Opinion on Therapeutic Patents|June 7, 2025
Nurr1 modulators - a patent review (2019-present)Markus Egner, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Development of Nuclear Receptor ModulatorsSimone Schierle, Daniel Merk
Journal of Medicinal Chemistry|November 2, 2023
Exploring Fatty Acid Mimetics as NR4A LigandsTanja Stiller, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2019
Hybrid Reporter Gene Assays: Versatile In Vitro Tools to Characterize Nuclear Receptor ModulatorsJan Heering, Daniel Merk
Chemical Communications (Cambridge, England)|March 31, 2023
Opportunities and challenges in targeting orphan nuclear receptorsLaura Isigkeit, Daniel Merk
Expert Opinion on Therapeutic Patents|July 13, 2019
Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patentsSimone Schierle, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
An Introduction to ChemogenomicsApirat Chaikuad, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Compilation of Custom Compound/Bioactivity Datasets from Public RepositoriesLaura Isigkeit, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
A Fluorescence-Based Reporter Gene Assay to Characterize Nuclear Receptor ModulatorsEspen Schallmayer, Daniel Merk
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Future Medicinal Chemistry|December 15, 2015
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatmentDaniel Merk
Expert Opinion on Therapeutic Patents|June 7, 2025
Nurr1 modulators - a patent review (2019-present)Markus Egner, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2018
Development of Nuclear Receptor ModulatorsSimone Schierle, Daniel Merk
Journal of Medicinal Chemistry|November 2, 2023
Exploring Fatty Acid Mimetics as NR4A LigandsTanja Stiller, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2019
Hybrid Reporter Gene Assays: Versatile In Vitro Tools to Characterize Nuclear Receptor ModulatorsJan Heering, Daniel Merk
Chemical Communications (Cambridge, England)|March 31, 2023
Opportunities and challenges in targeting orphan nuclear receptorsLaura Isigkeit, Daniel Merk
Expert Opinion on Therapeutic Patents|July 13, 2019
Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patentsSimone Schierle, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
An Introduction to ChemogenomicsApirat Chaikuad, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
Compilation of Custom Compound/Bioactivity Datasets from Public RepositoriesLaura Isigkeit, Daniel Merk
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2023
A Fluorescence-Based Reporter Gene Assay to Characterize Nuclear Receptor ModulatorsEspen Schallmayer, Daniel Merk
Pageof 17